Mack Gene 4
4 · Gain Therapeutics, Inc. · Filed Apr 8, 2024
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Employee Stock Option (right to buy)
2024-04-08+200,000→ 200,000 totalExercise: $3.56Exp: 2034-04-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest 25% on April 8, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.